Treatment to slow Alzheimer’s progression given in Cyprus for first time

A 72-year-old woman became the first patient in Cyprus to receive the monoclonal antibody donanemab, in a pioneering treatment for early-stage Alzheimer’s disease administered yesterday at Melathro Agoniston EOKA. Professor of Neurology at the University of Nicosia Giorgos…

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on In-Cyprus.